| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Japan Animal Referral Medical Center Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,097.00 |
| 52 Week High | JP¥2,099.00 |
| 52 Week Low | JP¥1,700.00 |
| Beta | 0.54 |
| 11 Month Change | 4.96% |
| 3 Month Change | 1.50% |
| 1 Year Change | 14.53% |
| 33 Year Change | 9.28% |
| 5 Year Change | -2.96% |
| Change since IPO | 27.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6039 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | 1.7% | -1.0% | -0.6% |
| 1Y | 14.5% | -3.0% | 17.8% |
Return vs Industry: 6039 exceeded the JP Healthcare industry which returned -3% over the past year.
Return vs Market: 6039 underperformed the JP Market which returned 17.8% over the past year.
Price Volatility
| 6039 volatility | |
|---|---|
| 6039 Average Weekly Movement | 2.4% |
| Healthcare Industry Average Movement | 3.4% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in JP Market | 7.4% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 6039 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6039's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 229 | Hidehiro Hirao | www.jarmec.co.jp |
Japan Animal Referral Medical Center Co., Ltd. owns and operates medical centers for animals in Japan. Its veterinary hospital provides advanced medical care service for dogs and cats.
Japan Animal Referral Medical Center Co., Ltd. Fundamentals Summary
| 6039 fundamental statistics | |
|---|---|
| Market cap | JP¥5.53b |
| Earnings (TTM) | JP¥337.00m |
| Revenue (TTM) | JP¥4.27b |
16.4x
P/E Ratio1.3x
P/S RatioIs 6039 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6039 income statement (TTM) | |
|---|---|
| Revenue | JP¥4.27b |
| Cost of Revenue | JP¥2.81b |
| Gross Profit | JP¥1.46b |
| Other Expenses | JP¥1.13b |
| Earnings | JP¥337.00m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 01, 2024
| Earnings per share (EPS) | 127.73 |
| Gross Margin | 34.29% |
| Net Profit Margin | 7.89% |
| Debt/Equity Ratio | 101.2% |
How did 6039 perform over the long term?
See historical performance and comparison